Observational Study
Copyright ©The Author(s) 2020.
World J Gastrointest Endosc. Apr 16, 2020; 12(4): 128-137
Published online Apr 16, 2020. doi: 10.4253/wjge.v12.i4.128
Table 1 Participants’ demographics (n = 1715)
Possible factors relating to discomfortMean (SD)
Age59 (11)
BMI23.5 (3.6)
Height163.1 (8.8)
Possible factors relating to discomfort number (%)
Age
≤ 3980 (4.7)
40-49308 (18.0)
50-59431 (25.1)
60-69610 (35.6)
≥ 70286 (16.7)
Male sex950 (55%)
BMI ≥ 25503 (29.3)
Height
< 150 cm114 (6.7)
150-160 cm546 (31.8)
160-170 cm644 (37.6)
≥ 170 cm411 (24.0)
Smoking status
Non-smoker988 (57.6)
Past-smoker487 (28.4)
Current-smoker240 (14.0)
Alcohol consumption
Non-drinker761 (44.4)
Normal drinker812 (47.4)
Heavy-drinker142 (8.3)
History of endoscopy1602 (93.4)
History of gastrectomy30 (1.8)
Butylscopolamine administration511 (29.8)
Biopsy performed49 (2.9)
Lugol’s solution use7 (0.4)
Small diameter endoscope1657 (96.6)
Hiatal hernia775 (45.2)
Sedative
None774 (45.1)
Pethidine797 (46.5)
Midazolam19 (1.1)
Pethidine and midazolam125 (7.3)
Table 2 Discomfort for each factor in the group without sedation (n = 774) and univariate analysis results
Discomfort score value median (quartile ranges)Proportion of high discomfort (score6)
Age
≤ 396 (4-8)P < 0.00160.5% (23/38)P < 0.001
40-494 (4-6)Kruskal-Wallis test45.1% (51/113)χ2 test
50-594 (2-6)34.7% (66/190)
60-694 (2-4)18.3% (48/262)
≥ 702 (0-4)9.9% (17/171)
Male sex4 (2-4)P < 0.00123.5% (130/554)P = 0.003
Female sex4 (2-6)Mann-Whitney U test34.1% (75/220)χ2 test
BMI
≥ 254 (2-6)P = 0.79627.2% (62/228)P = 0.773
< 254 (2-6)Mann-Whitney U test26.2% (143/546)χ2 test
Height
< 150 cm4 (2-5)P = 0.00725.7% (9/35)P = 0.219
150-160 cm4 (2-6)Kruskal-Wallis test29.4% (53/180)χ2 test
160-170 cm4 (2-4)22.7% (75/330)
≥ 170 cm4 (2-6)29.7% (68/229)
Non-smoker4 (2-6)P = 0.00326.5% (104/393)P = 0.033
Past smoker4 (2-4)Kruskal-Wallis test22.4% (57/255)χ2 test
Current smoker4 (2-6)34.9% (44/126)
Non-drinker4 (2-6)P = 0.09829.4% (91/309)P = 0.291
Normal drinker4 (2-4)Kruskal-Wallis test24.9% (96/386)χ2 test
Heavy drinker4 (2-4)22.8% (18/79)
History of endoscopy (+)4 (2-4)P < 0.00124.8% (180/727)P < 0.001
History of endoscopy (-)6 (4-7)Mann-Whitney U test53.2% (25/47)χ2 test
History of gastrectomy (+)2 (2-4)P = 0.20216.7% (3/18)P = 0.428
History of gastrectomy (-)4 (2-6)Mann-Whitney U test26.7% (202/756)Fisher's exact test
Butylscopolamine (+)2 (2-4)P = 0.11520.6% (14/68)P = 0.249
Butylscopolamine (-)4 (2-6)(Mann-Whitney U test27.1% (191/706)χ2 test
Biopsy performed (+)4 (2-6)P = 0.46139.1% (9/23)P = 0.163
Biopsy performed (-)4 (2-6)Mann-Whitney U test26.1% (196/751)χ2 test
Lugol’s solution (+)4 (2-6)P = 0.95040.0% (2/5)P = 0.612
Lugol’s solution (-)4 (2-6)(Mann-Whitney U test26.4% (203/769)Fisher's exact test
Endoscope
Normal diameter4 (2-6)P = 0.73728.6% (6/21)P = 0.826
Small diameter4 (2-6)Mann-Whitney U test26.4% (199/753)χ2 test
Hiatal hernia (+)4 (2-6)P = 0.25727.6% (113/410)P = 0.472
Hiatal hernia (-)4 (2-6)Mann-Whitney U test25.3% (92/364)χ2 test
Sedation agent
No use4 (2-6)-26.5% (205/774)-
Pethidine alone--
Midazolam alone--
Pethidine and Midazolam--
Table 3 Discomfort for each factor in the sedation group (n = 941) and univariate analysis results
Discomfort score value median (quartile ranges)Proportion of high discomfort (score 6 or higher)
Age
≤ 394 (2.5-6)P < 0.00140.5% (17/42)P < 0.001
40-492 (2-4)Kruskal-Wallis test17.9% (35/195)χ2 test
50-592 (0-4)10.8% (26/241)
60-692 (0-4)6.0% (21/348)
≥ 702 (0-2)3.5% (4/115)
Male sex2 (0-4)P < 0.00110.9% (43/396)P = 0.942
Female sex2 (2-4)Mann-Whitney U test11.0% (60/545)χ2 test
BMI
≥ 252 (0-4)P = 0.15511.3% (31/275)P = 0.837
< 252 (0-4)Mann-Whitney U test10.8% (72/666)χ2 test
Height
< 150 cm2 (1-4)P = 0.18513.9% (11/79)P = 0.109
150-160 cm2 (0-4)Kruskal-Wallis test9.6% (35/366)χ2 test
160-170 cm2 (0-4)9.2% (29/314)
≥ 170 cm2 (0-4)15.4% (28/182)
Non-smoker2 (0-4)P < 0.00110.1% (60/595)P = 0.055
Past smoker2 (0-4)Kruskal-Wallis test9.9% (23/232)χ2 test
Current smoker2 (2-4)17.5% (20/114)
Non-drinker2 (0-4)P = 0.0559.5% (43/452)P = 0.001
Normal drinker2 (0-4)Kruskal-Wallis test10.3% (44/426)χ2 test
Heavy drinker2 (1-5)25.4% (16/63)
History of endoscopy (+)2 (0-4)P = 0.00410.3% (90/875)P = 0.018
History of endoscopy (-)2 (2-4)Mann-Whitney U test19.7% (13/66)χ2 test
History of gastrectomy (+)2 (0-2.5)P = 0.47716.7% (2/12)P = 0.631
History of gastrectomy (-)2 (0-4)Mann-Whitney U test10.9% (101/929)Fisher's exact test
Butylscopolamine (+)2 (0-4)P = 0.18710.6% (47/443)P = 0.755
Butylscopolamine (-)2 (0-4)Mann-Whitney U test11.2% (56/498)χ2 test
Biopsy performed (+)2 (0-3.5)P = 0.28711.5% (3/26)P = 0.757
Biopsy performed (-)2 (0-4)Mann-Whitney U test10.9% (100/915)Fisher's exact test
Lugol’s solution (+)1 (0.5-1.5)P = 0.350.0% (0/2)P = 1.00
Lugol’s solution (-)2 (0-4)Mann-Whitney U test11.0% (103/939)Fisher's exact test
Endoscope
Normal diameter2 (2-4)P = 0.19710.8% (4/37)P = 1.00
Small diameter2 (0-4)Mann-Whitney U test11.0% (99/904)Fisher's exact test
Hiatal hernia (+)2 (0-4)P = 0.89112.3% (45/365)P = 0.279
Hiatal hernia (-)2 (0-4)Mann-Whitney U test10.1% (58/576)χ2 test
Sedation agent
No use--
Pethidine alone2 (0-4)P < 0.00111.7% (93/797)P = 0.186
Midazolam alone2 (0-4)Kruskal-Wallis test10.5% (2/19)Fisher's exact test
Pethidine and Midazolam0 (0-2)6.4% (8/125)
Table 4 Multiple regression analysis and impact of each factor for discomfort
Regression coefficientUpper limit of 95%CILower limit of 95%CIP value
Age (+ 1)-0.08-0.09-0.07< 0.001
Sex (male)-0.45-0.79-0.100.013
BMI (+ 1)-0.002-0.030.030.903
Height (+ 1)-0.02-0.04-0.0030.024
Smoking status
Past smoker-0.06-0.320.200.638
Current smoker0.350.020.670.036
Alcohol consumption
Normal drinker-0.05-0.270.180.680
Heavy drinker0.20-0.210.610.337
Has no endoscopic experience0.22-0.200.650.300
History of gastrectomy0.36-0.411.140.362
Butylscopolamine use-0.04-0.350.270.802
Biopsy performed0.11-0.510.720.729
Lugol’s solution use1.02-0.612.640.221
Normal diameter endoscope0.48-0.091.050.101
Hiatal hernia0.340.110.570.003
Sedation agent
Pethidine alone-1.47-1.71-1.22< 0.001
Midazolam alone-1.63-2.61-0.660.001
Pethidine and midazolam-2.92-3.36-2.49< 0.001